ATI Mental Health Practice Exam |
Psychopharmacology, Schizophrenia
& Mood Disorders
ATI Mental Health Practice Exam
ATI Mental
_ Psychopharmacology,
Health Practice Exam
Schizophrenia
ATI_ Mental
Psychopharmacology,
Health
& Mood
Practice
Disorders.pdf
Schizophrenia
Exam _ Psychopharmacology,
& Mood Disorders.pdf
Schizophrenia & Mood Disorders
,Page 2 of 38 2 of 38 2
Terms (76)
Hide definitions
Which neurotransmitter is inhibitory and the primary target of
benzodiazepines?
GABA
Comprehensive ATI Mental Health Practice Exam_
Comprehensive
Psychopharmacology,
ATI MentalSchizophrenia,
Health Practice
Mood
Exam_
Disorders.pdf
Psychopharmacology,
Comprehensive ATI Mental
Schizophrenia,
Health Practice
Mood Exam_
Disorders.pdf
Psychopharmacology, Schizophrenia, Mood Disorders
,Page 3 of 38 3 of 38 3
What is monoamine oxidase (MAO)?
MAO is an enzyme that deactivates monoamine
neurotransmitters.
What is the therapeutic serum range for lithium?
0.6-1.2 mEq/L
Comprehensive ATI Mental Health Practice Exam_
Comprehensive
Psychopharmacology,
ATI MentalSchizophrenia,
Health Practice
Mood
Exam_
Disorders.pdf
Psychopharmacology,
Comprehensive ATI Mental
Schizophrenia,
Health Practice
Mood Exam_
Disorders.pdf
Psychopharmacology, Schizophrenia, Mood Disorders
, Page 4 of 38 4 of 38 4
What is the expected onset of full therapeutic effect for
paroxetine?
4 to 6 weeks
Comprehensive ATI Mental Health Practice Exam_
Comprehensive
Psychopharmacology,
ATI MentalSchizophrenia,
Health Practice
Mood
Exam_
Disorders.pdf
Psychopharmacology,
Comprehensive ATI Mental
Schizophrenia,
Health Practice
Mood Exam_
Disorders.pdf
Psychopharmacology, Schizophrenia, Mood Disorders